Ozempic in Tokyo: Availability, Costs, and What Foreigners Need to Know

Ozempic — the brand name for semaglutide, a GLP-1 receptor agonist developed by Novo Nordisk — has become one of the most searched medications globally over the past several years.

Originally approved for the management of type 2 diabetes, its well-documented effects on weight reduction have driven demand far beyond its original indicated use.

For international patients in Tokyo, understanding how and where to access Ozempic in Japan requires navigating a regulatory and clinical landscape that differs significantly from the US, UK, and other markets.

This guide covers availability, cost, prescription requirements, and everything foreigners need to know before seeking Ozempic in Tokyo.

What Is Ozempic?

Ozempic (semaglutide 0.5mg, 1mg, and 2mg) is a once-weekly injectable GLP-1 receptor agonist approved for the treatment of type 2 diabetes in adults.

It works by mimicking the action of glucagon-like peptide-1, a hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and reduces appetite.

Its effects on body weight — significant enough to prompt a separate approval for the higher-dose formulation Wegovy (semaglutide 2.4mg) for chronic weight management in many markets — have driven global demand well beyond its original diabetic patient population.

Ozempic vs Wegovy

Ozempic and Wegovy both contain semaglutide but are approved for different indications and at different doses:

• Ozempic (0.5mg, 1mg, 2mg): approved for type 2 diabetes management
• Wegovy (2.4mg): approved specifically for chronic weight management in adults with obesity or overweight with weight-related comorbidities

In Japan, the regulatory status and availability of these two formulations differ — a distinction covered in detail below.

Ozempic Availability in Japan

Regulatory Approval Status

Ozempic received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for the treatment of type 2 diabetes.

It is a legitimate, approved medication in Japan and is available through the Japanese healthcare system for its approved indication.

Wegovy — the weight management formulation — received PMDA approval in 2023, making Japan one of the earlier markets in Asia to approve high-dose semaglutide for obesity treatment.

Supply Constraints

Japan, like many countries, has experienced periods of Ozempic supply shortage driven by global demand.

Availability can vary between clinics and pharmacies at any given time.

Before planning treatment around Ozempic specifically, it is worth confirming current availability with the clinic or pharmacy you intend to use.

Where It Is Available

Ozempic in Japan is dispensed through:

• Hospital pharmacies — for patients receiving treatment within the hospital system
• Retail pharmacies (調剤薬局) — with a valid Japanese prescription
• Aesthetic and weight loss clinics — for patients seeking it in a weight management context, where it may be prescribed off-label or, for Wegovy, on-label

Prescription Requirements in Japan

Medical Prescription Required

Ozempic is a prescription-only medication in Japan.

It cannot be purchased over the counter, obtained without a consultation, or legally imported for personal use without going through the appropriate channels.

A valid Japanese prescription from a licensed Japanese physician is required to dispense it through any Japanese pharmacy.

Type 2 Diabetes Indication

For the treatment of type 2 diabetes, Ozempic is prescribed through standard medical channels — general practitioners, internal medicine specialists, or endocrinologists.

Patients with a documented diagnosis of type 2 diabetes who are seeking Ozempic for its approved indication should be able to access it through these channels with appropriate supporting documentation of their diagnosis.

Weight Management Context

For patients seeking Ozempic or Wegovy specifically for weight management, the prescription pathway typically runs through:

• Weight loss clinics (美容外科・ダイエット外科) — clinics specialising in medical weight management that are equipped to prescribe GLP-1 medications
• Internal medicine clinics — where a physician assesses metabolic health and prescribes appropriately
• Some aesthetic medicine clinics — which have expanded into medical weight management services

A consultation including a health assessment — typically covering BMI, metabolic markers, and medical history — is required before prescription.

Clinics vary in their assessment rigour and prescribing criteria.

What Foreigners Need to Know About Accessing Ozempic in Tokyo

Continuing an Existing Prescription

If you are already taking Ozempic in your home country and wish to continue during a stay in Japan, the process is not automatic.

Japanese physicians are not obligated to continue prescriptions issued overseas, and you will need to undergo a fresh consultation with a Japanese doctor.

Bringing documentation of your existing prescription, relevant medical records, and your diagnosis will support the consultation process.

Short-Term Visitors

For short-term visitors to Tokyo, accessing Ozempic presents practical challenges.

The medication requires a Japanese prescription, a consultation, and regular injections — meaning it is most practical for patients staying for a meaningful period rather than those on brief visits.

If you are visiting for two weeks or less, carrying a sufficient supply from your home country (with appropriate documentation) is a more straightforward option, provided customs regulations permit personal medication import in the quantities required.

Japan’s Personal Import Allowance

Japan allows personal import of up to a one-month supply of most prescription medications for personal use when entering the country.

For quantities exceeding one month, a Yakkan Shoumei (薬監証明) — a prior import confirmation issued by the Ministry of Health, Labour and Welfare — is required.

If you intend to bring Ozempic into Japan, confirm the current allowance rules and obtain the necessary documentation in advance.

English-Language Clinics

For non-Japanese speakers, finding a clinic with English-speaking physicians or staff is particularly important for a medication consultation involving metabolic health history, current medications, and treatment goals.

Several clinics in Tokyo cater specifically to international patients and offer English-language consultations for weight management and metabolic health.

National Health Insurance

International patients on tourist or short-term visas are not enrolled in Japan’s national health insurance system.

All consultations and medications will be out of pocket.

Long-term residents enrolled in NHI may be able to access Ozempic for its diabetic indication through the insurance system, though coverage for weight management use is a separate consideration.

Ozempic Cost in Tokyo

Estimated Pricing

Pricing for Ozempic in Japan varies between clinics and depends on the dose and whether it is being prescribed through the insurance system or privately.
Product Estimated Monthly Cost (Private, JPY)

Ozempic 0.5mg (4 pens) ¥30,000 – ¥50,000
Ozempic 1mg (4 pens) ¥40,000 – ¥70,000
Wegovy 2.4mg (4 pens) ¥50,000 – ¥90,000
Initial consultation fee ¥3,000 – ¥15,000

Prices are approximate and subject to change. Supply fluctuations can affect availability and pricing.

Always confirm current pricing directly with the clinic or pharmacy.

Comparison with Other Markets

Ozempic in Japan is generally priced below US market rates for self-pay patients, though higher than in many European markets where national health systems negotiate pricing.

For international patients paying out of pocket, the Japanese private market represents a reasonable cost point by global standards.

How Ozempic Compares to Other GLP-1 Medications Available in Japan

Japan’s GLP-1 medication landscape has expanded considerably in recent years.

Understanding the alternatives to Ozempic helps patients and their physicians identify the most appropriate option.

Mounjaro (Tirzepatide)

Mounjaro (tirzepatide), developed by Eli Lilly, is a dual GIP/GLP-1 receptor agonist that has demonstrated weight loss outcomes exceeding those of semaglutide in head-to-head trials.

It received PMDA approval for type 2 diabetes and has generated significant interest in Japan’s weight management market.

For patients for whom Ozempic is unavailable due to supply constraints, Mounjaro represents the closest therapeutic alternative.

Victoza (Liraglutide)

Liraglutide (Victoza) is a daily injectable GLP-1 agonist that predates semaglutide and is available in Japan for type 2 diabetes management.

It is less potent for weight loss than semaglutide or tirzepatide but may be more readily available and is familiar to many Japanese physicians.

Oral Semaglutide (Rybelsus)

Rybelsus — the oral formulation of semaglutide — is available in Japan for type 2 diabetes.

For patients who prefer an oral option over a weekly injection, Rybelsus offers the same active ingredient as Ozempic in a daily tablet form, though at lower bioavailability.

Frequently Asked Questions

Is Ozempic legal in Japan?

Yes. Ozempic is a PMDA-approved medication in Japan and is legally available with a valid Japanese prescription for its approved indication.

It is not a controlled substance, but it is prescription-only and cannot be purchased without a consultation with a licensed Japanese physician.

Can I buy Ozempic online in Japan?

Purchasing prescription medications through unregulated online channels in Japan is illegal.

Only medications dispensed through licensed Japanese pharmacies with a valid prescription are legally obtained.

Be cautious of online sources claiming to sell Ozempic without a prescription — these are operating outside Japanese law and may supply counterfeit or unsafe product.

Does Ozempic require refrigeration?

Yes. Unused Ozempic pens should be stored in the refrigerator at 2–8°C.

Once in use, a pen can be kept at room temperature (up to 30°C) for up to 56 days.

This has practical implications for patients travelling — ensure appropriate storage is available at your accommodation.

Can I use Ozempic for weight loss in Japan if I am not diabetic?

For non-diabetic patients seeking semaglutide for weight management, Wegovy (the higher-dose formulation) is the appropriate on-label option in Japan for eligible patients.

Some clinics may prescribe Ozempic off-label for weight management purposes, though this varies by physician and clinic policy.

A thorough health assessment is required in either case.

How long does it take to see results from Ozempic?

Meaningful weight loss effects from semaglutide typically become apparent over eight to twelve weeks, with the most significant results achieved over six to twelve months of consistent use alongside dietary and lifestyle modification.

Glucose-lowering effects in diabetic patients begin more rapidly.

Final Thoughts

Ozempic is accessible in Japan for international patients, but navigating the prescription process requires understanding the local regulatory environment, finding a clinic with appropriate English-language support, and planning ahead — particularly for short-term visitors managing existing prescriptions or supply continuity.

The Japanese GLP-1 market is well-developed and continues to expand, offering genuine options for patients seeking both diabetes management and medically supervised weight loss.

As with any prescription medication, the quality of the prescribing consultation and the ongoing clinical support available from your clinic are the most important factors in a safe and effective treatment experience.